Maxillary Sinus DiseaseNCT06556225
Isolated Maxillary Sinus Lesions in Sohag University Hospital
An observational study of Maxillary Sinus Disease, run by Sohag University at 1 site in Egypt.
Trial summary
Aim of the study: Identify variants of maxillary sinus pathologies, its clinical presentations, radiological findings and surgical managements. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Maxillary Sinus Disease
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 10 Apr 2024to 1 Jan 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients with the isolated maxillary sinus lesions were subjected to 1. Detailed history, general clinical examination \& ENT examination, routine investigations, diagnostic nasal endoscopy. 2. CT scan PNS 3. The surgical approaches and intraoperative findings were recorded either endoscopicallay or combined approach . 4. The pathological diagnoses were reviewed postoperatively.
Who may be able to join
- Only patients with isolated maxillary sinus lesions , with varying degrees of sinus opacity who were indicated for surgery.
Who cannot join
- Patients who had pan sinuses lesions or those with significant involvement of the other paranasal sinuses than maxillary sinus were excluded.
Trial locations and contacts
1 site in 1 country.
sara mustafa contact
Egypt1 site, 1 recruiting
- Recruiting
Sohag Universty
Sohag
sara mustafa, 01003571546
arafat mahmoud, 01007642544
About this study
Aim of the study:
Identify variants of maxillary sinus pathologies, its clinical presentations, radiological findings and surgical managements.
Read the detailed description
Maxillary sinus diseases are common and numerous disorders that affect this anatomical area. As lesions are frequently allowed to grow to a significant size before becoming symptomatic, patients often present late, which can make management options more limited and difficult. Proper evaluation both clinically and with appropriate imaging allows accurate diagnosis, and lesions can often be successfully managed endoscopically
- Conditions
- Maxillary Sinus Disease
What is being measured
The primary outcome is the main question the study is designed to answer.
Identify variants of maxillary sinus pathologies, its clinical presentations, radiological findings and surgical managements.
All the collected data will be analyzed using the Statistical Package for Social Sciences (SPSS) (SPSS Inc., Chicago, IL, USA)v22.
Measured: will be at Sohag University Hospital, a tertiary care academic center in Egypt, from 2023 to 2024
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Aug 2024
- Study start10 Apr 2024
- Primary completion1 Nov 2024 (estimated)
- Study completion1 Jan 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Maxillary Sinus DiseaseStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Karam Ali Alameldin, Sohag University
- Investigators
- arafat mahmoud, Study chair, sohag universty
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06556225
- Sponsor's protocol ID
- Soh-Med-24-04-018MS
- Status last verified
- Aug 2024
- First submitted
- 20 Jul 2024
- Last updated
- 15 Aug 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Isolated Maxillary Sinus Lesions in Sohag University Hospital
- ClinicalTrials.gov ID
- NCT06556225
- Acronym / sponsor ID
- Soh-Med-24-04-018MS
- Conditions
- Maxillary Sinus Disease
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 10 Apr 2024 (actual)
- Primary completion
- 1 Nov 2024 (estimated)
- Study completion
- 1 Jan 2025 (estimated)
- First posted
- 15 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim of the study:
Identify variants of maxillary sinus pathologies, its clinical presentations, radiological findings and surgical managements.
Detailed description
Maxillary sinus diseases are common and numerous disorders that affect this anatomical area. As lesions are frequently allowed to grow to a significant size before becoming symptomatic, patients often present late, which can make management options more limited and difficult. Proper evaluation both clinically and with appropriate imaging allows accurate diagnosis, and lesions can often be successfully managed endoscopically
Study design
- Observational model
- Other
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients with the isolated maxillary sinus lesions were subjected to 1. Detailed history, general clinical examination \& ENT examination, routine investigations, diagnostic nasal endoscopy. 2. CT scan PNS 3. The surgical approaches and intraoperative findings were recorded either endoscopicallay or combined approach . 4. The pathological diagnoses were reviewed postoperatively.
Key inclusion criteria (1 listed)
- Only patients with isolated maxillary sinus lesions , with varying degrees of sinus opacity who were indicated for surgery.
Key exclusion criteria (1 listed)
- Patients who had pan sinuses lesions or those with significant involvement of the other paranasal sinuses than maxillary sinus were excluded.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Identify variants of maxillary sinus pathologies, its clinical presentations, radiological findings and surgical managements.
Time frame: will be at Sohag University Hospital, a tertiary care academic center in Egypt, from 2023 to 2024
All the collected data will be analyzed using the Statistical Package for Social Sciences (SPSS) (SPSS Inc., Chicago, IL, USA)v22.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Aug 2024.
- Individual participant dataSharing planned: No
Related trials for Maxillary Sinus Disease
Recruiting
Two Bovine Xenografts in Lateral Window Sinus Augmentation With or Without Bone Marrow Blood
Alveolar Bone Loss, Sinus Floor Augmentation
Recruiting
The Application of a Biphasic Calcium Sulfate Graft Material in Sinus Floor Elevation
Alveolar Bone Loss, Edentulism Nos
Not yet recruiting
Buccal Periosteal Inversion Flap vs Buccal Advancement Flap for Acute Oro-Antral Communication Closure
Acute Oroantral Communication
Active, not recruitingPhase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Head and Neck Carcinoma, Malignant Parotid Gland Neoplasm
RecruitingPhase 1
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
sara mustafa contact
arafat mahmoud study chair
sohag universty
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Maxillary Sinus Disease, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 15 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact karam ali (01067895670, karamaly34@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Identify variants of maxillary sinus pathologies, its clinical presentations, radiological findings and surgical managements. (time frame: will be at Sohag University Hospital, a tertiary care academic center in Egypt, from 2023 to 2024). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2024.